Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fergus Caskey

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Journal of the American Society of Nephrology : JASN|March 9, 2021
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKDChava L Ramspek, Marie Evans, Christoph Wanner, et al.
Clinical Kidney Journal|December 13, 2024
Prescribing patterns in older people with advanced chronic kidney disease towards the end of lifeMatthew Letts, Nicholas C Chesnaye, Maria Pippias, et al.
Archives of Osteoporosis|September 17, 2021
Correction to: Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, DenmarkM Sanni Ali, Martin Ernst, Danielle E Robinson, et al.
Archives of Osteoporosis|June 3, 2020
Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, DenmarkM Sanni Ali, Martin Ernst, Danielle E Robinson, et al.
Health Technology Assessment (Winchester, England)|March 19, 2021
Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort studyDanielle E Robinson, M Sanni Ali, Victoria Y Strauss, et al.
BMC Medical Research Methodology|February 12, 2022
Converting from face-to-face to postal follow-up and its effects on participant retention, response rates and errors: lessons from the EQUAL study in the UKEmer Gates, Barnaby Hole, Samantha Hayward, et al.
Health Technology Assessment (Winchester, England)|August 4, 2025
BioImpedance Spectroscopy to maintain Renal Output: the BISTRO randomised controlled trialSimon J Davies, David Coyle, Elizabeth Lindley, et al.
Kidney International|May 16, 2014
Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney diseaseEdwin M Spithoven, Anneke Kramer, Esther Meijer, et al.
BMJ Open|March 24, 2022
Global eHealth capacity: secondary analysis of WHO data on eHealth and implications for kidney care delivery in low-resource settingsIkechi G Okpechi, Shezel Muneer, Feng Ye, et al.
BMJ Global Health|January 19, 2021
Workforce capacity for the care of patients with kidney failure across world countries and regionsParnian Riaz, Fergus Caskey, Mark McIsaac, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Journal of the American Society of Nephrology : JASN|March 9, 2021
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKDChava L Ramspek, Marie Evans, Christoph Wanner, et al.
Clinical Kidney Journal|December 13, 2024
Prescribing patterns in older people with advanced chronic kidney disease towards the end of lifeMatthew Letts, Nicholas C Chesnaye, Maria Pippias, et al.
Archives of Osteoporosis|September 17, 2021
Correction to: Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, DenmarkM Sanni Ali, Martin Ernst, Danielle E Robinson, et al.
Archives of Osteoporosis|June 3, 2020
Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, DenmarkM Sanni Ali, Martin Ernst, Danielle E Robinson, et al.
Health Technology Assessment (Winchester, England)|March 19, 2021
Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort studyDanielle E Robinson, M Sanni Ali, Victoria Y Strauss, et al.
BMC Medical Research Methodology|February 12, 2022
Converting from face-to-face to postal follow-up and its effects on participant retention, response rates and errors: lessons from the EQUAL study in the UKEmer Gates, Barnaby Hole, Samantha Hayward, et al.
Health Technology Assessment (Winchester, England)|August 4, 2025
BioImpedance Spectroscopy to maintain Renal Output: the BISTRO randomised controlled trialSimon J Davies, David Coyle, Elizabeth Lindley, et al.
Kidney International|May 16, 2014
Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney diseaseEdwin M Spithoven, Anneke Kramer, Esther Meijer, et al.
BMJ Open|March 24, 2022
Global eHealth capacity: secondary analysis of WHO data on eHealth and implications for kidney care delivery in low-resource settingsIkechi G Okpechi, Shezel Muneer, Feng Ye, et al.
BMJ Global Health|January 19, 2021
Workforce capacity for the care of patients with kidney failure across world countries and regionsParnian Riaz, Fergus Caskey, Mark McIsaac, et al.
Pageof 7